NAFLD (Non-Alcohol Fatty Liver Disease) Activity Score

The NAFLD Activity Score quantifies histologic disease activity by summing steatosis, lobular inflammation, and hepatocellular ballooning 1.

Steatosis (grade): low- to medium-power evaluation of parenchymal involvement by steatosis
< 5%05-33%+134-66%+2> 66%+3
Inflammation (lobular): overall assessment of all inflammatory foci
No foci01 focus per 200x field+12-4 foci per 200x field+2> 4 foci per 200x field+3
Liver cell injury (ballooning)
None0Few balloon cells+1Many cells/prominent ballooning+2

Indications for Use

Used to grade histologic disease activity on liver biopsy by summing steatosis, lobular inflammation, and ballooning to quantify NASH severity only for clinical trials and tracking histologic change, not for diagnosing NASH (poor specificity) 1 [Level I evidence]; misclassification risk shown in a 976‑patient cohort 2 [Level II evidence]. Guides treatment endpoints (e.g., ≥2‑point NAS improvement without fibrosis worsening) 3 [Level III evidence].

Insights & Cautions

Reflects biopsy‑graded steatosis, lobular inflammation, and ballooning to track histologic activity, but does not diagnose NASH and should not be used alone for clinical decision‑making 1 [Level III evidence]. Interpretation is limited by sampling error and interobserver variability 2 [Level III evidence]. Higher scores correlate with enzymes and disease activity but poorly predict outcomes, as fibrosis—not NAS—drives prognosis 3 [Level II evidence].